Effect of Aerobic Exercises Versus Incentive Spirometer Device on Post-covid Pulmonary Fibrosis Patients
NCT ID: NCT06191367
Last Updated: 2024-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
45 participants
INTERVENTIONAL
2022-02-01
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Pulmonary Rehabilitation Program on Post Hospitalization Severe COVID- 19 Patients
NCT05476835
Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID
NCT04639349
Breather Trainer Versus Pulmonary Rehabilitation on Cardiopulmonary Efficiency
NCT05382780
Incentive Spirometry in Routine Management of COPD Patients
NCT05679609
The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19
NCT04357340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, this study may open up ways to other researchers to investigate and build up on this effect if present and address such an important issue.
The finding of this proposed work may help patients with post-covid syndrome and complain of lung diseases by addressing their complains of symptoms like chest pain, dyspnea, and cough and provide a possible solution to enhance their quality of life and increase their participation in daily life activities.
Patients of post-covid syndrome with residual lung problems will be recruited after approval of ethical committee of the faculty of physical therapy, Cairo university. All participants will sign a written informed consent form.
The subjects will be randomly assigned into one of three groups:
* Group I (experimental) will receive aerobic exercises program and traditional chest physiotherapy.
* Group II (experimental) will receive incentive spirometer device treatment and traditional chest physiotherapy.
* Group III (control) will receive traditional chest physiotherapy only. The measures will be taken before and after treatment program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (experimental) Aerobic Exercises and Traditional Chest Physiotherapy.
It was consisted of fifteen patients with positive covid-19 test from at least a month before trial. They received aerobic exercise techniques which consist of 3 levels of activity exercises and traditional program of chest physiotherapy. (Five times per week for two months).
Aerobic Exercises
Aerobic Exercises
Traditional Chest Physiotherapy
1. Breathing exercise.
2. Postural drainage.
3. Percussion.
4. Coughing.
5. Vibration.
Group II (experimental)Incentive Spirometer Device and Traditional Chest Physiotherapy.
It was consisted of fifteen patients with positive covid-19 test from at least a month before trial. They received incentive spirometer training techniques and traditional program of chest physiotherapy. (Five times per week for two months).
Incentive Spirometer Device
is a handheld medical device used to help patients improve the functioning of their lungs. By training patients to take slow and deep breaths, this simplified spirometer facilitates lung expansion and strengthening. Patients inhale through a mouthpiece, which causes a piston inside the device to rise. This visual feedback helps them monitor their inspiratory effort. Incentive spirometers are commonly used after surgery or other illnesses to prevent pulmonary complications.
Traditional Chest Physiotherapy
1. Breathing exercise.
2. Postural drainage.
3. Percussion.
4. Coughing.
5. Vibration.
Group III (control) will receive Traditional Chest Physiotherapy only.
As a control group it was consisted of fifteen patients with positive covid-19 test from at least a month before trial. They received traditional program of chest physiotherapy only. (Five times per week for two months).
for example: - Breathing Exercises. - Postural Drainage. - Percussion. - Coughing - Vibration.
Traditional Chest Physiotherapy
1. Breathing exercise.
2. Postural drainage.
3. Percussion.
4. Coughing.
5. Vibration.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic Exercises
Aerobic Exercises
Incentive Spirometer Device
is a handheld medical device used to help patients improve the functioning of their lungs. By training patients to take slow and deep breaths, this simplified spirometer facilitates lung expansion and strengthening. Patients inhale through a mouthpiece, which causes a piston inside the device to rise. This visual feedback helps them monitor their inspiratory effort. Incentive spirometers are commonly used after surgery or other illnesses to prevent pulmonary complications.
Traditional Chest Physiotherapy
1. Breathing exercise.
2. Postural drainage.
3. Percussion.
4. Coughing.
5. Vibration.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age from 40 to 85 years.
* Both sexes.
* All patients were positive covid-19 infected patients and passed at least 4 weeks after confirmation.
* All patients suffer from respiratory complications.
* All patients included are actively breathing.
* All patients included are fully aware and conscious.
Exclusion Criteria
* Severe Head Injury.
* Increased intracranial pressure.
* Anemic Hb\<8.
* Active Smoking.
* Severe Bronchospasm.
* Low BP (systole \<80, diastole \<60).
* Subcutaneous Emphysema.
* Rip Fractures.
* Untreated Pneumothorax.
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
McCarious Nahad Aziz Abdelshaheed Stephens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
McCarious Nahad Aziz Abdelshaheed Stephens
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed H Elgendy, Doctoral
Role: PRINCIPAL_INVESTIGATOR
Physiotherapy Faculty, Cairo University.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Physiotherapy department Police Academy Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CairoU post-covid PF Rehab
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.